Bank Of New York Mellon Corp Durect Corp Transaction History

Bank Of New York Mellon Corp

$541 Trillion
Q4 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.38 - $0.64 $223,698 - $376,754	-588,679 Reduced 86.32%	93,307 $45,000
Q4 2021 Feb 11, 2022	BUY	$0.9 - $1.31 $10,981 - $15,984	12,202 Added 1.82%	681,986 $672,000
Q3 2021 Nov 12, 2021	BUY	$1.21 - $1.61 $60,470 - $80,461	49,976 Added 8.06%	669,784 $857,000
Q2 2021 Aug 11, 2021	SELL	$1.6 - $2.02 $130,676 - $164,979	-81,673 Reduced 11.64%	619,808 $1.01 Million
Q1 2021 May 13, 2021	SELL	$1.86 - $2.87 $43,018 - $66,377	-23,128 Reduced 3.19%	701,481 $1.39 Million
Q4 2020 Feb 09, 2021	SELL	$1.65 - $2.43 $28,063 - $41,329	-17,008 Reduced 2.29%	724,609 $1.5 Million
Q3 2020 Nov 12, 2020	SELL	$1.6 - $2.35 $3,844 - $5,647	-2,403 Reduced 0.32%	741,617 $1.27 Million
Q2 2020 Aug 12, 2020	BUY	$1.33 - $2.76 $845,719 - $1.76 Million	635,879 Added 588.01%	744,020 $1.73 Million
Q1 2020 May 06, 2020	SELL	$0.97 - $2.85 $23,732 - $69,730	-24,467 Reduced 18.45%	108,141 $167,000
Q3 2019 Nov 07, 2019	BUY	$0.61 - $2.21 $22,255 - $80,629	36,484 Added 37.96%	132,608 $243,000
Q2 2019 Aug 12, 2019	SELL	$0.51 - $0.86 $179,396 - $302,511	-351,758 Reduced 78.54%	96,124 $63,000
Q1 2019 May 14, 2019	SELL	$0.51 - $0.82 $1,405 - $2,259	-2,756 Reduced 0.61%	447,882 $280,000
Q4 2018 Feb 11, 2019	SELL	$0.48 - $1.1 $2,745 - $6,290	-5,719 Reduced 1.25%	450,638 $218,000
Q3 2018 Nov 09, 2018	BUY	$1.06 - $1.69 $3,099 - $4,941	2,924 Added 0.64%	456,357 $0
Q2 2018 Aug 06, 2018	BUY	$1.56 - $2.51 $39,343 - $63,302	25,220 Added 5.89%	453,433 $707,000
Q1 2018 May 15, 2018	BUY	$0.91 - $2.24 $26,431 - $65,063	29,046 Added 7.28%	428,213 $916,000
Q4 2017 Feb 09, 2018	BUY	$0.78 - $2.1 $311,350 - $838,250	399,167	399,167 $368,000

Others Institutions Holding DRRX

# of Institutions

Shares Held

593K

Call Options Held

Put Options Held

View Full List

About DURECT CORP

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $173M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

More about DRRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account